Crossmark

Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway

Published Online: 2021-08-06

Published Print: 2021-12

Authors

Chen, Xiaojun

Zhang, Weixia

Xu, Xiuzhen
License Information

Text and Data Mining valid from 2021-08-06

Version of Record valid from 2021-08-06
More Information

Article History

Received: 9 April 2021

Accepted: 17 July 2021

First Online: 6 August 2021

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no conflicts of interest.

Document is current